Hostname: page-component-586b7cd67f-rcrh6 Total loading time: 0 Render date: 2024-11-30T04:35:28.918Z Has data issue: false hasContentIssue false
  • English
  • Français

Real-world effectiveness of infection prevention interventions for reducing procedure-related cardiac device infections: Insights from the veterans affairs clinical assessment reporting and tracking program

Published online by Cambridge University Press:  04 June 2019

Archana Asundi ,
Maggie Stanislawski ,
Payal Mehta ,
Anna E. Baron ,
Hillary J. Mull ,
P. Michael Ho ,
Peter J. Zimetbaum ,
Kalpana Gupta  and
Westyn Branch-Elliman
Archana Asundi
Affiliation:
Division of Infectious Diseases, Boston Medical Center, Boston, Massachusetts
Maggie Stanislawski
Affiliation:
Seattle-Denver Center of Innovation for Veteran-Centered and Value-Driven Care, Seattle, Washington, and Denver, Colorado Department of Epidemiology, University of Colorado School of Public Health, Aurora, Colorado Division of Cardiology, Rocky Mountain Regional VA Medical Center, Aurora, Colorado
Payal Mehta
Affiliation:
Department of Medicine, Division of Infectious Diseases, Boston VA Healthcare System, West Roxbury, Massachusetts
Anna E. Baron
Affiliation:
Department of Epidemiology, University of Colorado School of Public Health, Aurora, Colorado
Hillary J. Mull
Affiliation:
Center for Healthcare Organization and Implementation Research (CHOIR), Boston Veterans Affairs Healthcare System, Boston, Massachusetts
P. Michael Ho
Affiliation:
Seattle-Denver Center of Innovation for Veteran-Centered and Value-Driven Care, Seattle, Washington, and Denver, Colorado Division of Cardiology, Rocky Mountain Regional VA Medical Center, Aurora, Colorado Department of Medicine, Division of Cardiology, University of Colorado School of Medicine, Aurora, Colorado
Peter J. Zimetbaum
Affiliation:
Division of Cardiology, Beth Israel Deaconess Medical Center, Boston, Massachusetts Harvard Medical School, Boston, Massachusetts
Kalpana Gupta
Affiliation:
Department of Medicine, Division of Infectious Diseases, Boston VA Healthcare System, West Roxbury, Massachusetts Center for Healthcare Organization and Implementation Research (CHOIR), Boston Veterans Affairs Healthcare System, Boston, Massachusetts Boston University School of Medicine, Boston, Massachusetts
Westyn Branch-Elliman*
Affiliation:
Department of Medicine, Division of Infectious Diseases, Boston VA Healthcare System, West Roxbury, Massachusetts Center for Healthcare Organization and Implementation Research (CHOIR), Boston Veterans Affairs Healthcare System, Boston, Massachusetts Harvard Medical School, Boston, Massachusetts
*
Author for correspondence: Westyn Branch-Elliman, Email: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

To measure the association between receipt of specific infection prevention interventions and procedure-related cardiac implantable electronic device (CIED) infections.

Design:

Retrospective cohort with manually reviewed infection status.

Setting:

Setting: National, multicenter Veterans Health Administration (VA) cohort.

Participants:

Sampling of procedures entered into the VA Clinical Assessment Reporting and Tracking-Electrophysiology (CART-EP) database from fiscal years 2008 through 2015.

Methods:

A sample of procedures entered into the CART-EP database underwent manual review for occurrence of CIED infection and other clinical/procedural variables. The primary outcome was 6-month incidence of CIED infection. Measures of association were calculated using multivariable generalized estimating equations logistic regression.

Results:

We identified 101 procedure-related CIED infections among 2,098 procedures (4.8% of reviewed sample). Factors associated with increased odds of infections included (1) wound complications (adjusted odds ratio [aOR], 8.74; 95% confidence interval [CI], 3.16–24.20), (2) revisions including generator changes (aOR, 2.4; 95% CI, 1.59–3.63), (3) an elevated international normalized ratio (INR) >1.5 (aOR, 1.56; 95% CI, 1.12–2.18), and (4) methicillin-resistant Staphylococcus colonization (aOR, 9.56; 95% CI, 1.55–27.77). Clinically effective prevention interventions included preprocedural skin cleaning with chlorhexidine versus other topical agents (aOR, 0.41; 95% CI, 0.22–0.76) and receipt of β-lactam antimicrobial prophylaxis versus vancomycin (aOR, 0.60; 95% CI, 0.37–0.96). The use of mesh pockets and continuation of antimicrobial prophylaxis after skin closure were not associated with reduced infection risk.

Conclusions:

These findings regarding the real-world clinical effectiveness of different prevention strategies can be applied to the development of evidence-based protocols and infection prevention guidelines specific to the electrophysiology laboratory.

Type
Original Article
Information
Infection Control & Hospital Epidemiology , Volume 40 , Issue 8 , August 2019 , pp. 855 - 862
Copyright
© 2019 by The Society for Healthcare Epidemiology of America. All rights reserved. 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

PREVIOUS PRESENTATION: This work was presented as a poster abstract (no. 2126) at IDWeek 2018, on October 6, 2018, in San Francisco, California.

References

Greenspon, AJ, Patel, JD, Lau, E, et al. 16-year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States, 1993–2008. J Am Coll Cardiol 2011;58:1001–1006.CrossRefGoogle Scholar
Greenspon, AJ, Patel, JD, Lau, E, et al. Trends in permanent pacemaker implantation in the United States from 1993 to 2009: increasing complexity of patients and procedures. J Am Coll Cardiol 2012;60:1540–1545.CrossRefGoogle ScholarPubMed
Mehrotra, P, Gupta, K, Strymish, J, et al. Implementation of infection prevention and antimicrobial stewardship in cardiac electrophysiology laboratories: results from the SHEA Research Network. Infect Control Hosp Epidemiol 2017;38:496–498.CrossRefGoogle ScholarPubMed
de Oliveira, JC, Martinelli, M, Nishioka, SA, et al. Efficacy of antibiotic prophylaxis before the implantation of pacemakers and cardioverter-defibrillators: results of a large, prospective, randomized, double-blinded, placebo-controlled trial. Circ Arrhythm Electrophysiol 2009;2:29–34.CrossRefGoogle ScholarPubMed
Strymish, J, Welch, B, Peralta, A, et al. Implementation of a surgical site infection prevention bundle in the cardiac electrophysiology laboratory for management of a cluster of device infections. Open Forum Infect Dis 2016;3:S1.CrossRefGoogle Scholar
Ali, S, Kanjwal, Y, Bruhl, SR, et al. A meta-analysis of antibacterial envelope use in prevention of cardiovascular implantable electronic device infection. Therapeut Adv Infect Dis 2017;4:75–82.CrossRefGoogle ScholarPubMed
Ahsan, SY, Saberwal, B, Lambiase, PD, et al. A simple infection-control protocol to reduce serious cardiac device infections. Europace 2014;16:1482–1489.CrossRefGoogle ScholarPubMed
Manolis, AS, Melita, H. Prevention of cardiac implantable electronic device infections: single operator technique with use of povidone-iodine, double gloving, meticulous aseptic/antiseptic measures and antibiotic prophylaxis. Pacing Clin Electrophysiol 2017;40:26–34.CrossRefGoogle ScholarPubMed
Krahn, AD, Longtin, Y, Philippon, F, et al. Prevention of arrhythmia device infection trial: the PADIT trial. J Am Coll Cardiol 2018;72:3098–3109.CrossRefGoogle ScholarPubMed
Polyzos, KA, Konstantelias, AA, Falagas, ME. Risk factors for cardiac implantable electronic device infection: a systematic review and meta-analysis. Europace 2015;17:767–777.CrossRefGoogle ScholarPubMed
Nichols, CI, Vose, JG. Incidence of bleeding-related complications during primary implantation and replacement of cardiac implantable electronic devices. J Am Heart Assoc 2017;6:pii: e004263.CrossRefGoogle ScholarPubMed
Branch-Elliman, W, Stanislawski, M, Strymish, J, et al. Cardiac electrophysiology laboratories: a potential target for antimicrobial stewardship and quality improvement? Infect Control Hosp Epidemiol 2016;37:1005–1011.CrossRefGoogle ScholarPubMed
Baddour, LM, Epstein, AE, Erickson, CC, et al. Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association. Circulation 2010;121:458–477.CrossRefGoogle ScholarPubMed
Sandoe, JA, Barlow, G, Chambers, JB, et al. Guidelines for the diagnosis, prevention and management of implantable cardiac electronic device infection. Report of a joint Working Party project on behalf of the British Society for Antimicrobial Chemotherapy (BSAC, host organization), British Heart Rhythm Society (BHRS), British Cardiovascular Society (BCS), British Heart Valve Society (BHVS) and British Society for Echocardiography (BSE). J Antimicrob Chemother 2015;70:325–359.CrossRefGoogle Scholar
Nielsen, JC, Gerdes, JC, Varma, N. Infected cardiac-implantable electronic devices: prevention, diagnosis, and treatment. Eur Heart J 2015;36:2484–2490.CrossRefGoogle Scholar
Epitools: Epidemiology Tools. R package version 0.5-92017 [computer program].Google Scholar
Elixhauser, A, Steiner, C, Harris, DR, Coffey, RM. Comorbidity measures for use with administrative data. Med Care 1998;36:8–27.CrossRefGoogle ScholarPubMed
R: A Language and Environment for Statistical Computing [computer program]. Vienna, Austria: R Foundation for Statistical Computing; 2017.Google Scholar
Asundi, A, Stanislawski, M, Mehta, P, et al. Prolonged antimicrobial prophylaxis following cardiac device procedures increases preventable harm: insights from the VA CART program. Infect Control Hosp Epidemiol 2018;39:1030–1036.CrossRefGoogle ScholarPubMed
Chen, HC, Chen, MC, Chen, YL, et al. Bundled preparation of skin antisepsis decreases the risk of cardiac implantable electronic device-related infection. Europace 2016;18:858–867.CrossRefGoogle ScholarPubMed
George, S, Leasure, AR, Horstmanshof, D. Effectiveness of decolonization with chlorhexidine and mupirocin in reducing surgical site infections: a systematic review. Dimen Crit Care Nurs 2016;35:204–222.CrossRefGoogle ScholarPubMed
Lee, WH, Huang, TC, Lin, LJ, et al. Efficacy of postoperative prophylactic antibiotics in reducing permanent pacemaker infections. Clin Cardiol 2017;40:559–565.CrossRefGoogle ScholarPubMed
Basil, A, Lubitz, SA, Noseworthy, PA, et al. Periprocedural antibiotic prophylaxis for cardiac implantable electrical device procedures: results from a Heart Rhythm Society survey. JACC Clin Electrophysiol 2017;3:632–634.CrossRefGoogle ScholarPubMed
Bratzler, DW. Surgical care improvement project performance measures: good but not perfect. Clin Infect Dis 2013;56:428–429.CrossRefGoogle Scholar
Harbarth, S, Samore, MH, Lichtenberg, D, Carmeli, Y. Prolonged antibiotic prophylaxis after cardiovascular surgery and its effect on surgical site infections and antimicrobial resistance. Circulation 2000;101:2916–2921.CrossRefGoogle ScholarPubMed
Rosenberger, LH, Politano, AD, Sawyer, RG. The surgical care improvement project and prevention of post-operative infection, including surgical site infection. Surg Infect (Larchmt) 2011;12:163–168.CrossRefGoogle ScholarPubMed
Bratzler, DW, Houck, PM, Richards, C, et al. Use of antimicrobial prophylaxis for major surgery: baseline results from the National Surgical Infection Prevention Project. Arch Surg 2005;140:174–182.CrossRefGoogle ScholarPubMed
Bratzler, DW, Dellinger, EP, Olsen, KM, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health Syst Pharm 2013;70:195–283.CrossRefGoogle ScholarPubMed
Bolon, MK, Morlote, M, Weber, SG, et al. Glycopeptides are no more effective than beta-lactam agents for prevention of surgical site infection after cardiac surgery: a meta-analysis. Clin Infect Dis 2004;38:1357–1363.CrossRefGoogle ScholarPubMed
Kang, FG, Liu, PJ, Liang, LY, et al. Effect of pocket irrigation with antimicrobial on prevention of pacemaker pocket infection: a meta-analysis. BMC Cardiovasc Disord 2017;17:256.CrossRefGoogle ScholarPubMed
Lakshmanadoss, U, Nuanez, B, Kutinsky, I, et al. Incidence of pocket infection postcardiac device implantation using antibiotic versus saline solution for pocket irrigation. Pacing Clin Electrophysiol 2016;39:978–984.CrossRefGoogle ScholarPubMed
Edin, ML, Miclau, T, Lester, GE, Lindsey, RW, Dahners, LE. Effect of cefazolin and vancomycin on osteoblasts in vitro. Clin Orthop Relat Res 1996:245–251.Google ScholarPubMed
Henrikson, CA, Sohail, MR, Acosta, H, et al. Antibacterial envelope is associated with low infection rates after implantable cardioverter-defibrillator and cardiac resynchronization therapy device replacement: results of the citadel and centurion studies. JACC Clin Electrophysiol 2017;3:1158–1167.CrossRefGoogle ScholarPubMed
Koerber, SM, Turagam, MK, Winterfield, J, Gautam, S, Gold, MR. Use of antibiotic envelopes to prevent cardiac implantable electronic device infections: a meta-analysis. J Cardio Electrophysiol 2018;29:609–615.CrossRefGoogle ScholarPubMed
Tarakji, KG, Mittal, S, Kennergren, C, et al. Antibacterial envelope to prevent cardiac implantable device infection. N Engl J Med 2019. doi: 10.1056/NEJMoa1901111. [Epub ahead of print].CrossRefGoogle ScholarPubMed
Turagam, MK, Nagarajan, DV, Bartus, K, Makkar, A, Swarup, V. Use of a pocket compression device for the prevention and treatment of pocket hematoma after pacemaker and defibrillator implantation (STOP-HEMATOMA-I). J Intervent Cardiac Electrophysiol 2017;49:197–204.CrossRefGoogle Scholar
Douketis, JD. Perioperative management of patients who are receiving warfarin therapy: an evidence-based and practical approach. Blood 2011;117:5044–5049.CrossRefGoogle ScholarPubMed
Pindyck, T, Gupta, K, Strymish, J, et al. Validation of an electronic tool for flagging surgical site infections based on clinical practice patterns for triaging surveillance: operational successes and barriers. Am J Infect Control 2018;46:186–190.CrossRefGoogle ScholarPubMed
Supplementary material: File

Asundi et al. supplementary material

Asundi et al. supplementary material 1

Download Asundi et al. supplementary material(File)
File 53 KB